Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lizhu Lin

Showing results (101-110 of 147) with videos related to

Pageof 15
Sort By:
Developmental Biology|July 4, 2017
Tissue specific requirements for WNT11 in developing outflow tract and dorsal mesenchymal protrusionPatrick P van Vliet, Lizhu Lin, Cornelis J Boogerd, et al.
Circulation Research|June 8, 2013
HCN4 dynamically marks the first heart field and conduction system precursorsXingqun Liang, Gang Wang, Lizhu Lin, et al.
Molecular Medicine Reports|December 12, 2018
Salvianolic acid B, an antioxidant derived from Salvia militarize, protects mice against γ‑radiation‑induced damage through Nrf2/Bach1Ruifang Zhou, Haishan Long, Bei Zhang, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 15, 2019
Yiqi Chutan Tang Reduces Gefitinib-Induced Drug Resistance in Non-Small-Cell Lung Cancer by Targeting Apoptosis and AutophagyJue Zhang, Lingling Sun, Jian Cui, et al.
Journal of Global Oncology|December 16, 2017
Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and CancerJeffrey D White, Hongsheng Lin, Libin Jia, et al.
Medicinal Research Reviews|June 20, 2021
Recent pharmacological advances in the repurposing of artemisinin drugsYuqing Meng, Nan Ma, Haining Lyu, et al.
Integrative Cancer Therapies|January 30, 2023
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot StudyWenmin Chen, Jietao Lin, Ting Yang, et al.
Frontiers in Oncology|October 5, 2020
Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling PathwayXiaozhong Liao, Lanting Tao, Wei Guo, et al.
The American Journal of Chinese Medicine|October 5, 2018
Sophora flavescens Containing-QYJD Formula Activates Nrf2 Anti-Oxidant Response, Blocks Cellular Transformation and Protects Against DSS-Induced Colitis in Mouse ModelRuoming Fang, Renyi Wu, Qian Zuo, et al.
Development (Cambridge, England)|March 25, 2006
Isl1Cre reveals a common Bmp pathway in heart and limb developmentLei Yang, Chen-Leng Cai, Lizhu Lin, et al.
Pageof 15

Showing results (101-110 of 147) with videos related to

Sort By:
Pageof 15
Developmental Biology|July 4, 2017
Tissue specific requirements for WNT11 in developing outflow tract and dorsal mesenchymal protrusionPatrick P van Vliet, Lizhu Lin, Cornelis J Boogerd, et al.
Circulation Research|June 8, 2013
HCN4 dynamically marks the first heart field and conduction system precursorsXingqun Liang, Gang Wang, Lizhu Lin, et al.
Molecular Medicine Reports|December 12, 2018
Salvianolic acid B, an antioxidant derived from Salvia militarize, protects mice against γ‑radiation‑induced damage through Nrf2/Bach1Ruifang Zhou, Haishan Long, Bei Zhang, et al.
Cytometry. Part a : the Journal of the International Society for Analytical Cytology|August 15, 2019
Yiqi Chutan Tang Reduces Gefitinib-Induced Drug Resistance in Non-Small-Cell Lung Cancer by Targeting Apoptosis and AutophagyJue Zhang, Lingling Sun, Jian Cui, et al.
Journal of Global Oncology|December 16, 2017
Proceedings of the Strategy Meeting for the Development of an International Consortium for Chinese Medicine and CancerJeffrey D White, Hongsheng Lin, Libin Jia, et al.
Medicinal Research Reviews|June 20, 2021
Recent pharmacological advances in the repurposing of artemisinin drugsYuqing Meng, Nan Ma, Haining Lyu, et al.
Integrative Cancer Therapies|January 30, 2023
Yifei Sanjie Formula or Placebo With Anlotinib as Second-Line or Above Treatment for Metastatic Non-Small-Cell Lung Cancer: Study Protocol for a Double-Blind, Placebo-Controlled Randomized Pilot StudyWenmin Chen, Jietao Lin, Ting Yang, et al.
Frontiers in Oncology|October 5, 2020
Combination of Cordycepin and Apatinib Synergistically Inhibits NSCLC Cells by Down-Regulating VEGF/PI3K/Akt Signaling PathwayXiaozhong Liao, Lanting Tao, Wei Guo, et al.
The American Journal of Chinese Medicine|October 5, 2018
Sophora flavescens Containing-QYJD Formula Activates Nrf2 Anti-Oxidant Response, Blocks Cellular Transformation and Protects Against DSS-Induced Colitis in Mouse ModelRuoming Fang, Renyi Wu, Qian Zuo, et al.
Development (Cambridge, England)|March 25, 2006
Isl1Cre reveals a common Bmp pathway in heart and limb developmentLei Yang, Chen-Leng Cai, Lizhu Lin, et al.
Pageof 15